Ondine Biomedical Inc on Thursday said a new study has proven its Steriwave photodisinfection technology ‘highly effective’ against drug-resistant pathogens on human tissues.

The Vancouver-based life sciences company, which specialises in photodisinfection therapies, said the study showed Steriwave to be ‘highly effective’ against both moderately and extensively drug resistant bacteria, killing over 99.99% of pathogens in 20 seconds.

‘The research underlines the potential for Steriwave to become a rapid, broad-spectrum, bactericidal alternative to antibiotics,’ Ondine commented.

The company said Steriwave employs patented technology to ‘rapidly and safely’ eliminate bacteria, funghi and viruses located on human tissues.

‘Overuse of antibiotics over decades has caused adaptation in many microbes, and we now see multidrug resistance evolving into extensive drug resistance in bacteria, rendering even the most powerful combination of drugs ineffective,’ said Chief Technology Officer Nicolas Loebel. ‘We believe photodisinfection can play a significant role in cost-effectively combatting these drug-resistant pathogens and reducing global reliance on antibiotics.

‘We know of no other antimicrobial that can match the performance, safety, and cost benefits of photodisinfection.’

Shares in Ondine were up 0.2% at 9.77 pence in London on Thursday afternoon.

Copyright 2023 Alliance News Ltd. All Rights Reserved.